Cell Therapy For Corneal Endothelial Dystrophies With Aurion Biotech's Greg Kunst

We love to hear from our listeners. Send us a message.

For this third and final episode recorded at ARM's 2023 Meeting on the Mesa, Cell & Gene: The Podcast Host, Erin Harris, sat down with Greg Kunst, president, CEO, and Board member at Aurion Biotech. Listen in as they discuss the cell therapy used to treat corneal endothelial disease and how Greg navigated the event as a first-timer attending Meeting on the Mesa.

Subscribe to the podcast!
Apple | Spotify | YouTube